Table 2.
Clinical data | HR (95% CI) | P value |
---|---|---|
Overall survival (OS) | ||
Node stage (N+ vs. N0) | 3.17 (1.33-4.90) | 0.023 |
TNM stage (III/IV vs. I/II) | 4.36 (1.56-7.23) | 0.008 |
Tissue miR-31 (high vs. low) | 3.31 (1.42-5.36) | 0.015 |
Disease-free survival (DFS) | ||
Node stage (N+ vs. N0) | 3.52 (1.42-5.69) | 0.017 |
TNM stage (III/IV vs. I/II) | 4.57 (1.71-7.54) | 0.001 |
Tissue miR-31 (high vs. low) | 3.86 (1.53-6.05) | 0.009 |